MyFinsight
Home
About
Contact
bcyc: the income statement
Download
Download image
Total comprehensive
loss
-$59,208K
(-11.93%↓ Y/Y)
Foreign currency
translation adjustment
-$108K
(94.84%↑ Y/Y)
Net loss
-$59,100K
(-16.33%↓ Y/Y)
Interest and other income
$6,700K
(-36.69%↓ Y/Y)
Provision for (benefit
from) income taxes
$205K
(105.95%↑ Y/Y)
Net loss before
income tax provision
-$58,895K
(-8.56%↓ Y/Y)
Total other income,
net
$6,656K
(-30.64%↓ Y/Y)
Genentech
$6,537K
(1054.95%↑ Y/Y)
Ionis Collaboration
Agreement
$2,000K
Novartis Collaboration
Agreement
$2,181K
Bayer
$1,016K
(21.82%↑ Y/Y)
Interest expense
$44K
(33.33%↑ Y/Y)
Loss from operations
-$65,551K
(-2.67%↓ Y/Y)
Collaboration revenue
$11,734K
(338.49%↑ Y/Y)
Total operating
expenses
$77,285K
(16.18%↑ Y/Y)
General and
administrative
$18,859K
(3.30%↑ Y/Y)
Research and development
$58,426K
(21.05%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
BICYCLE THERAPEUTICS PLC (BCYC)
BICYCLE THERAPEUTICS PLC (BCYC)